Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy
luvqs / Pixabay

Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy

According to a story from BioSpace, a global collaborative called the Trajectory Analysis Project recently released a study that utilized the North Star Ambulatory Assessment (NSAA), a recently developed measurement…

Continue Reading Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy
New Partnership Aims to Develop Treatment for Huntington’s Disease
rawpixel / Pixabay

New Partnership Aims to Develop Treatment for Huntington’s Disease

According to a story from ncbiotech.org, a new partnership between Vertex Pharmaceuticals and RNA-based therapeutics company Ribometrix aims to develop potential treatments for serious diseases, including Huntington's disease, which is…

Continue Reading New Partnership Aims to Develop Treatment for Huntington’s Disease
Company Awarded Grant to Conduct Amyotrophic Lateral Sclerosis Clinical Trial
kschneider2991 / Pixabay

Company Awarded Grant to Conduct Amyotrophic Lateral Sclerosis Clinical Trial

According to a story from PR Newswire, the biopharmaceutical company Clene Nanomedicine, Inc., has issued an announcement in regards to its Australian subsidiary. This subsidiary has been awarded a grant…

Continue Reading Company Awarded Grant to Conduct Amyotrophic Lateral Sclerosis Clinical Trial
Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help
Devanath / Pixabay

Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help

According to a story from offspring.lifehacker.com, medical abnormalities and conditions that affect the skin are often something that many of us will notice on our own. Once a skin problem…

Continue Reading Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help
New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy
skeeze / Pixabay

New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy

According to a story from pmlive.com, the gene therapy company Bluebird Bio's latest recently released results from the company's phase 2/3 clinical trial demonstrates further encouraging data for its Lenti-D…

Continue Reading New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy
Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation
geralt / Pixabay

Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation

According to a story from Biotech 365, the immuno-oncology company Mateon Therapeutics Inc. has recently announced that the company's investigational product candidate OT101 has earned the US Food and Drug…

Continue Reading Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation
After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
jarmoluk / Pixabay

After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease

According to a story from Wales Online, Samantha Josey's childhood was characterized by unpleasant symptoms and health problems, resulting in hospital visits and bouts of serious illness. Her symptoms included…

Continue Reading After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients
rawpixel / Pixabay

The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients

The Center for Chronic Illness is a nonprofit group that is based out of Seattle, Washington. The goals of this organization include the provision of support and educational resources to…

Continue Reading The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients
A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation
Pexels / Pixabay

A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation

According to a story from Financial Buzz, the biotherapeutics company Bellerophon Therapeutics Inc. has recently announced that it has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation